Literature DB >> 18545773

The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory.

Vitor Tumas1, Guilherme Gustavo Ricioppo Rodrigues, Tarsis Leonardo Almeida Farias, José Alexandre S Crippa.   

Abstract

OBJECTIVE: Evaluate the accuracy of diagnosis of major depression in patients with Parkinson's disease (PD) using the UPDRS, the 15-item Geriatric Depression Scale (GDS15) and the Beck Depression Inventory (BDI).
METHOD: 50 consecutive patients with PD were evaluated. The diagnosis of major depression was made according to the DSM-IV criteria.
RESULTS: We found a 24% prevalence of major depression. All depression scales were highly correlated but UPDRS depression item had the lowest diagnostic value. The GDS15 had the more appropriate "receiver operating characteristics" curve. The best cut-off scores for screening depression were 17/18 for BDI and 8/9 for GDS15. We did not find any correlation between the level of depression and intensity of motor symptoms, functional capacity and duration of the disease.
CONCLUSION: GDS15 is better than the BDI and the UPDRS for screening depression in PD and depression is not related to the degree of parkinsonian symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18545773     DOI: 10.1590/s0004-282x2008000200002

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  15 in total

1.  Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCA.

Authors:  B Hanna-Pladdy; A Enslein; M Fray; B J Gajewski; R Pahwa; K E Lyons
Journal:  Int J Neurosci       Date:  2010-08       Impact factor: 2.292

Review 2.  Detecting depression in Parkinson disease: A systematic review and meta-analysis.

Authors:  Zahra Goodarzi; Kelly J Mrklas; Derek J Roberts; Nathalie Jette; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

3.  Quality of life and depressive symptoms in Chagas disease patients.

Authors:  Yaeko Ozaki; Maria Elena Guariento; Eros Antonio de Almeida
Journal:  Qual Life Res       Date:  2010-11-03       Impact factor: 4.147

4.  Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease.

Authors:  Paula Scalzo; Arthur Kümmer; Thales Lage Bretas; Francisco Cardoso; Antônio Lúcio Teixeira
Journal:  J Neurol       Date:  2009-10-22       Impact factor: 4.849

5.  Higher dopamine transporter density in Parkinson's disease patients with depression.

Authors:  Andre C Felicio; Tais S Moriyama; Clecio Godeiro-Junior; Ming C Shih; Marcelo Q Hoexter; Vanderci Borges; Sonia M A Silva; Edson Amaro-Junior; Luiz A F Andrade; Henrique B Ferraz; Rodrigo A Bressan
Journal:  Psychopharmacology (Berl)       Date:  2010-05-22       Impact factor: 4.530

6.  Components of depression in Parkinson disease.

Authors:  Laura B Zahodne; Michael Marsiske; Michael S Okun; Dawn Bowers
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-08-01       Impact factor: 2.680

7.  Neurologists' diagnostic accuracy of depression and cognitive problems in patients with parkinsonism.

Authors:  Angela E P Bouwmans; Wim E J Weber
Journal:  BMC Neurol       Date:  2012-06-15       Impact factor: 2.474

Review 8.  Emotional dysfunction in Parkinson's disease.

Authors:  Lee X Blonder; John T Slevin
Journal:  Behav Neurol       Date:  2011       Impact factor: 3.342

9.  Increased Prevalence of Non-motor Symptoms in Essential Tremor.

Authors:  Annie Lacerte; Sylvain Chouinard; Nicolas Jodoin; Geneviève Bernard; Guy A Rouleau; Michel Panisset
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-09-02

10.  Disease-Related Variables and Depression Among Iranian Patients with Parkinson Disease.

Authors:  Jalal Shakeri; Maryam Chaghazardi; Nasrin Abdoli; Farid Arman; Seyed Davood Hoseini; Hania Shakeri
Journal:  Iran Red Crescent Med J       Date:  2015-10-28       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.